Leriglitazone API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Leriglitazone API 146062-44-4?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Leriglitazone. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Leriglitazone
- Synonyms:
- 2,4-thiazolidinedione, 5-((4-(2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy)phenyl)methyl)- , All-ambo-5-((4-(2-(5-(1-hydroxyethyl)pyridin-2-yl)ethoxy)phenyl)methyl)-1,3-thiazole-2,4(3H,5H)-dione , Hydroxypioglitazone , Leriglitazone
- Cas Number:
- 146062-44-4
- DrugBank number:
- DB15021
- Unique Ingredient Identifier:
- K824X25AYA
General Description:
Leriglitazone, identified by CAS number 146062-44-4, is a notable compound with significant therapeutic applications. Leriglitazone is under investigation in clinical trial NCT03917225 (A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients).
Classification:
Leriglitazone belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring, classified under the direct parent group Phenol ethers. This compound is a part of the Organic compounds, falling under the Benzenoids superclass, and categorized within the Phenol ethers class, specifically within the None subclass.
Categories:
Leriglitazone is categorized under the following therapeutic classes: Sulfur Compounds, Thiazoles. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
